secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2026-08-06T20:06:24+00:00
Accession:  0001683168-26-006049
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01, 8.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Valion Bio achieves first milestone under Statera license; issues preferred shares for $750K payment
--------------------------------------------------------------------------------

- Achieved first milestone: validation of inventory for distribution and sales, triggering $750K payment.
- Issued 1,287.8685 Series A Preferred shares to Statera and Avenue as partial consideration.
- Milestone relates to Entolimod for Acute Radiation Syndrome (ARS) under A&R License Agreement.
- Remaining ARS milestones total $1.75M; Neutropenia milestones up to $2.75M if option exercised.
- Securities issued as unregistered, exempt under Section 4(a)(2) and Regulation D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826006049/0001683168-26-006049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826006049/valion_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-006049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer